| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Revenue | $5.89B | -3.7% |
| Cost of Revenue | $2.07B | -4.9% |
| Gross Profit | $3.82B | -3.0% |
| R&D Expense | $123.0M | -3.0% |
| SG&A Expense | $3.10B | -1.9% |
| Operating Income | $241.1M | -55.9% |
| Pre-tax Income | -$344.8M | -268.6% |
| Income Tax | $5.4M | -94.3% |
| Net Income | -$367.9M |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $257.1M | -14.5% |
| Accounts Receivable | $526.4M | +19.2% |
| Inventory | $794.5M | +4.0% |
| Current Assets | $1.95B | -0.5% |
| Total Assets | $11.91B | -1.4% |
| Current Liabilities | $2.54B | -2.4% |
| Long-term Debt | $3.96B | +3.0% |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $492.6M | -19.9% |
| Investing Cash Flow | -$128.4M | +43.2% |
| Financing Cash Flow | -$426.8M | -26.8% |
| -511.5% |
| EPS (Basic) | -$0.44 | -588.9% |
| EPS (Diluted) | -$0.44 | -588.9% |
| Total Liabilities |
| $7.95B |
| +1.5% |
| Stockholders' Equity | $3.54B | -7.4% |